Introduction
Primary hepatocytes are used extensively in pharmacology and toxicology research for predicting the metabolism of xenobiotics and drug components (Tirona et al., 2003) . Also, numerous animal studies and several human applications have suggested a prominent role of hepatocytes in future cell therapy protocols (Gupta, 2002) . For preparation of sufficient numbers of human hepatocytes, however, the lack of suitable donor tissues remains an obstacle. Stem cells, which can be propagated and differentiated in culture, are considered as ideal source for functional hepatocytes. Hepatic stem cells have been described in murine and human livers and have been used to generate hepatocytes, but significant numbers necessary for therapeutic application have not been generated (Zhang et al., 2003 ). An alternative source for primary hepatocytes are embryonic (ES) stem cells which have almost unlimited proliferation capabilities while retaining the potential to differentiate in vitro into various progenitor cells (Chinzei et al., 2002) .
The transcriptional events involved in the formation of liverspecific progenitor cells from pluripotent ES cells are poorly understood. Several groups have shown that pluripotent murine ES cells can differentiate into cells with a presumed hepatic phenotype in culture and integrate and function after transplantation into a host liver (Hamazaki et al., 2001; Jones et al., 2002) .
Although differentiation of hepatic progenitor cells into mature adult hepatocytes may occur in vivo after transplantation into an appropriate environment, it is currently not known whether differentiation into hepatic cells with complex metabolic functions can be achieved under current cell culture conditions in vitro (Miyashita et al., 2002; . It is likely that ES cell differentiation in culture is driven by transcriptional events similar to those seen in early organogenesis in vivo. At the molecular level the induction of liver development and its progress is characterized by the expression of TF such as hepatocyte nuclear factors (HNF)-1, HNF-3, HNF-4, HNF-6 and CCAAT/ enhancer binding proteins (C/EBP). These so-called "liver-enriched" TF show a specific expression pattern during organogenesis with a distinct narrow time interval of transcription initiation. Most of these TF, although not themselves liver-specific, are also known to regulate the expression of genes coding for important secretory liver proteins by combinatorial interaction on their promoters in preand postnatal liver (Nacer-Cherif et al., 2003) . Among these proteins, AFP is expressed already in early hepatoblasts and later on with increasing levels throughout the fetal development. After birth the AFP gene is selectively silenced (Jones et al., 2001) . In contrast, the ALB gene codes for the most abundant serum protein synthesized by the mature liver (Kamiya et al., 1999) .
Expression profiles in embryonic liver tissue of the "liverenriched" TF and the developmentally regulated ALB and AFP genes may thus represent paradigms for gene regulation in ES cell derived hepatic progenitors cells (ES-HPC) (Lazarevich et al., 2000) . In our present study we have analyzed the liver -enriched transcription factors and developmentally regulated genes in mouse liver development. On the basis of these expression data we aimed at understanding the volatile transcriptional events initiated during transition of pluripotent ES cells toward cells with a hepatic phenotype and to provide a new tool to characterize the phenotype of ES-HPC.
Results

ALB and AFP expression in pre-and postnatal murine liver samples
Quantitative levels of ALB and AFP mRNA expression normalized to the internal reference gene GAPDH at various stages of development are shown in Fig. 1 A,B. AFP expression was found at low levels in E d9.5 liver tissue. The levels in fetal mouse liver steadily increased ~ 1000-fold from day 9.5 to 15.5 of gestation and dropped dramatically in adult liver. However, at low levels, AFP was reproducibly detected in multiple adult liver samples by "real time" RT-PCR (Fig. 1A) . From E d10.5 on ALB mRNA expression increased continuously and reached maximum in adult liver (Fig.   1B ). ALB expression in hepatocytes immediately after isolation, 24 and 48 hours after culture was lower compared to adult liver tissue (Fig. 4) .
Liver-enriched TF expression in pre-and postnatal liver samples
Compared to ALB and AFP, expression of transcription factors were several fold lower. HNF-1α transcripts were first determined in early liver organogenesis at E d9.5. No signal was obtained in E d7.5 total embryonic tissue. The mRNA transcription level of HNF1α decreased substantially in liver tissue at E d13.5 and showed slightly higher levels again in adult liver tissue. A considerable level of HNF-1β mRNA expression was detected only in RNA samples from d 7.5 embryonic tissue and from E d9.5 as well as E d11.5 liver tissue. No signal was detected with the standard protocol nor using an increased amount or cDNA synthesized from PolyA(+)-mRNA at later stages. Expression of HNF3α mRNA reached maximal levels in early embryonic liver at E d11.5 and significantly dropped in liver tissue from E d13.5 mice and in adult liver. No signal was detected in d7.5 total embryonic tissue.
Overall, the HNF-3β signal was low and reached similar levels of transcription in whole embryonic tissue at day 7.5 and in liver tissue at E d9.5, d11.5 and E d13.5 of gestation. Pooled RNA samples from E d10.5 liver were also analyzed, which showed levels similar to E d11.5 and E d13.5 liver tissue (data not shown). In adult liver the transcription rate was consistently higher compared to early stage tissues. HNF-3β/GAPDH -ratio was ~ 10-fold lower compared to the average ratio detected for HNF-3α/ GAPDH in our tissue samples. HNF-4α and HNF-6 mRNA expression were highly expressed at E d9.5 and E d11.5 in the liver and showed significant lower levels in E d13.5 liver tissue and in adult liver. Both TF mRNAs were not detectable by "real time" RT-PCR in tissue from d7.5 whole embryo.
The highest levels of C/EBPα mRNA were detected in adult liver tissue. Only marginal levels were detected in E d13.5 and E d16.5 (data not shown) fetal liver. At earlier stages of liver (Fig. 3 A-E, for details see legend). The number of ALB-positive cells increased with differentiation time from day 5+10 to day 5+20, whereas no significant changes were detected in comparison to day 5+30. AFP was produced in up to 15, 22 and 6 % of the cells at stages 5+10d, 20d and 30d, respectively. Neither AFP nor ALB was detected in undifferentiated ES cells (Fig. 3E ). As expected from immunofluorescence staining, ALB and AFP mRNA expression was readily measured in ES-HPC cells, but was not detectable in undifferentiated ES cells. The level of expression, however, was lower compared to cultured adult hepatocytes or adult liver tissue. The levels of ALB expression corresponded to the levels detected in tissue samples from E d 10.5 -11.5 fetal liver. Cultured adult hepatocytes expressed ALB at a lower level than primary tissue, but expression levels were still several magnitudes higher than in ES-HPC cells.
Using "real time" RT-PCR HNF-3β, HNF-4α organogenesis, the transcription factor was not detectable. Among the analyzed liver-enriched TF, the highest number of mRNA copies relative to GAPDH were detected for C/EBPβ in the liver of adult mice. C/EBPβ mRNA was detected at all stages of embryonic development, but at a lower level compared to adult liver .
Expression profiles of the TF HNF-1α/β, HNF-3α/β, HNF-4α, HNF-6 and C/EBPα and β are summarized in Fig. 2 . The curves were approximated from the "real time" RT-PCR data that were generated for each TF at all stages of liver development studied. and HNF-6 mRNA´s were detected in cell samples after 5 days of embryoid body formation and 10, 20 or 30 days of hepatic differentiation. HNF-3β levels were also detected in undifferentiated ES cells but increased about three fold after differentiation induction. C/EBPα was not detectable in ES cells, but was readily detectable in cultured adult hepatocytes. C/EBPβ was not useful for the analysis of differentiation in ES cells, because the TF was highly expressed also in mouse embryonic feeder cells (data not shown). Figure 5 shows the expression rates of the TF HNF3β, 
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HNF-4α and HNF-6 in various ES-derived cell samples. The level of expression varied throughout the differentiation period, but overall reached the expression rates of primary cultured hepatocytes.
Discussion
The lack of an accessible adult liver stem cell compartment has fostered studies of hepatocyte differentiation during embryonic and fetal development . Analysis of embryonic and fetal gene expression patterns has become particularly important with the recent development of cell culture protocols that generate cells of hepatic phenotypes from pluripotent ES cells (Chinzei et al., 2002) . At the molecular level the induction of embryonic liver development is characterized by the expression of an array of TF. These so called "liver-enriched" TF have their own specific expression pattern during liver development with a distinct narrow time interval of transcriptional initiation. "Knock out" -experiments in mice have generated important data on function, time course and position of TF gene expression, and their putative roles in liver organogenesis have been extensively reviewed (Schrem et al., 2002) . Little, however, is known about quantitative levels of expression, and how these expression levels relate to various stages of liver development. Our "real-time" RT-PCR analysis shows a striking similarity concerning the pattern as well as the levels found in the developing liver for HNF-1α HNF-3α, HNF-4α and HNF-6 TF. The common profile of these mRNAs is characterized by absence in the embryo at E d7.5, when the liver has not yet developed, followed by a strong increase in the liver bud at E d9.5 and d 11.5 and finally resulting in a decrease at E d13.5 and a stable to slightly increased expression level in adult liver tissue. The peak levels of expression in liver tissue at E d9.5 and E d11.5 indicate, that these TF actively participate in the differentiation cascades and suggest a role as "early phase" priming factors for organ differentiation.
The profile of expression as well as the narrow time frame of peak expression also implicates a role of these TF during transition of pluripotent ES cells into ES-HPC. The ES-HPC show expression of all the TF identified as being upregulated in the early phase of organogenesis. During the time of hepatic differentiation in culture (d10, d20, d30), however, we observed considerable fluctuation of expression levels. This is not surprising, because hepatic differentiation is still incomplete and most likely generates a mosaique pattern of differentiation levels among the cells with a hepatic phenotype.
Whole-mount in situ hybridization showed HNF-3β expression in mouse embryos between days 6.5 and 9.5 of gestation (Sasaki and Hogan, 1993) . Detection by RT-PCR in E d7.5 embryos and continuous expression at all stages of liver development, although at very low levels, are in agreement with the known functions of the TF in node, notochord, and visceral endoderm development. HNF-3β mRNA was present in undifferentiated ES cells at low levels despite strong expression of Oct-4 mRNA indicating the maintenance of a pluripotent phenotype (Tomioka et al., 2002) . Upon hepatic differentiation, HNF3β mRNA was expressed at levels ~3x higher than the levels observed in pluripotent ES cells. Interestingly, it has recently been shown that ES cells expressing the HNF-3β gene as a transgene, predominantly differentiate into cells with a hepatic phenotype. These observations and our data underline the view that HNF-3β, in addition to its known function as a transcriptional activator in the adult liver, acts as a competency factor for hepatic specialization during embryogenesis in vivo as well as in ES cells (Ishizaka et al., 2002) .
Several groups have shown that HNF-4α is expressed in cells of the developing hepatic diverticulum from E d8.75 on, and that the TF plays a pivotal role for liver maturation and differentiation in HNF3β expressing endodermal tissue (Duncan et al., 1994; Taraviras et al., 1994) . Quantitative analysis shows a profound induction of expression in E d9.5 and d11.5 liver tissue. Similar to HNF-4α, TF HNF-6 is also maximally expressed during this early phase of liver development. Considerable expression of both genes was detected in ES-HPC, but not in undifferentiated ES cells, and levels were stable with minor fluctuations throughout the differentiation period. Although the expression levels were measured at three different time points during hepatic differentiation, the individual time of expression initiation could not be determined for HNF-4α and HNF-6 genes. There are, however, some hints from transfection assays that HNF-4α is regulated by HNF-6, because of its expression slightly later than HNF-6 (Cereghini, 1996) .
C/EBPα belongs to a later stage of the transcriptional hierarchy
and is associated with maintenance of a quiescent, mature state of adult hepatocytes (Kuo et al., 1990 The method of quantitative gene expression profiling by "real time" RT-PCR as applied in our study is limited by the fact, that both the analyzed tissue and ES-derived populations consist of more than one cell compartment. During fetal development, the liver is the site of hematopoiesis and the number of non-hepatocytes varies over time (Sonoda et al., 2001) . In particular, the analysis of the E d13.5 liver tissue may have been confounded by the presence of blood forming cells. In a previous study, microarray analysis of fetal liver showed extensive expression of genes known to be involved in hematopoiesis and studies are underway to combine laser microdissection techniques and linear amplification of mRNA with quantitative RT-PCR to increase the specificity of the results .
Our gene expression profiling of murine liver development indicates that ES-HPC express many of the "early phase" TF (in the range of levels observed for E d10.5-11.5 fetal liver tissue), which are known to be involved in hepatic specification. The lack of "late phase" TF such as CEBPα and low levels of ALB and AFP expression, however, point to an immature hepatic phenotype of the ES-HPC. The ES-HPC maturation state may have important consequences, when experimental or therapeutic applications are considered, since immature ES-HPC may lack the necessary metabolic competence in extracorporal liver assist devices, cell transplantation or drug toxicity studies. Transgene expression of liver specific genes and histotypic culture similarly as recently shown for pancreatic differentiation and/ or technologies to separate ES-HPC have to be applied to improve the differentiation and maturation status of hepatic cells.
Materials and Methods
Staging and preparation of embryos
Mouse embryos (all extra-embryonic parts of the embryo were removed) at various stages of gestation as well as liver tissue of 8 weeks old adult mice were obtained by mating random-bred BALB/C animals. At noon of the day of vaginal plug appearance was considered to be embryonic day 0.5.
RNA preparation and characterization
RNA was prepared using the Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) according to standard protocols. Residual chromosomal DNA was digested with DNase I (Life Technologies, Karlsruhe, Germany). The Agilent 2100 Bioanalyzer and the RNA 6000 LabChip kit (Agilent Technologies, Waldbronn, Germany) were used to determine the concentration and TaqMan probe: agccgggccctgagtaatcacctt purity/integrity of the RNA samples. Chips were prepared according to the protocol of the manufacturer: 12 samples (1 µl each) (concentrations ranging from 25-250 ng/µl) were loaded into sample wells of the chip.
Synthesis of cDNA
First strand cDNA was synthesized from 5 µg of total RNA in a 20 µl reaction using an oligo(dT) primer (Unip 2). One µl of the primer was mixed with 5 µg of total RNA or 1 µg PolyA (+) -RNA, and sterile double distilled water was added to a total volume of 12 µl. The mixture was incubated at 70ºC for 10 min and quickly chilled on ice. After a centrifugation step 4 µl of 5 x first strand buffer, 2 µl of 0.1 M DTT and 1 µl of 10 mM dNTP -mix were added. The contents were gently mixed and incubated at 42ºC for 2 min. 1 µl of the enzyme SuperscriptII (Life Technologies, Karlsruhe, Germany) was added. The reaction was continued for 50 min at 42ºC, followed by heating the solution at 70ºC for 15 min for inactivation.
Oligonucleotide and TaqMan probe design
Primer sequences and TaqMan probes for "real-time" RT-PCR were designed using the primer design software "Primer3" of the Whitehead Institute for Biomedical Research, Boston, and purchased from suppliers (MWG Biotech, Ebersberg, Germany and PE Applied Biosystems, Weiterstadt, Germany). Primer and TaqMan probe sequences are shown in Table 1 .
"Real -time" RT -PCR analysis
RNA expression normalized to the house keeping gene GAPDH was measured by "real-time" RT -PCR with the iCycler System (BIO-RAD, München, Germany) using the iCycler iQ Real-Time Detection System Software (Version 2.1). Optimal reaction conditions were 40 cycles of a twophase PCR (denaturation at 95ºC for 15 s; annealing at 55ºC for 30 s) after an initial denaturation step (95ºC for 10 min).
The TaqMan probes were labelled with a fluorescent reporter dye (6-carboxy-fluorescein [FAM] ) at the 5' end and a fluorescent quencher dye (6-carboxy-tetramethyl-rhodamine [TAMRA]) at the 3' end. Using the "Standard Curve Method" as described in the User Bulletin #2; ABI PRISM 7700 Detection System,the target gene expression was determined for each stage of 3-5 individual samples and from each cDNA sample at least 3 PCR -reactions were performed from both the target gene and the internal reference gene (GAPDH) to normalize for differences in individual sample concentration and experimental handling. The amount of target and endogenous reference concentrations were then determined from the appropriate standard curve and the unit from the standard curve drops out. The amount of the target mRNA was divided by the amount of GAPDH mRNA for normalization of target values under recognition of the dilution factor, e.g., iCycler experiments were run with cDNA, equivalent to 20 ng whole RNA for the measurement of transcription factors and only 0.5 ng were needed to obtain reasonable C t -values for AFP and ALB.
Standard curves
For demonstrating linearity of the assay system a standard curve for each target gene was calculated from serial dilutions of the cDNA template by plotting the log value of the starting concentration versus the threshold cycle (C t ). The amount of the target and the internal reference gene GAPDH in each tissue sample were calculated from standard curves using cDNA dilutions from a single lot of pooled mouse embryonic liver cDNA (E d13.5, Quantum Appligene, Heidelberg, Germany, ECDLI 135, Lot: FA3-1a ) or from liver cDNA of adult mice (Ambion Inc., Austin, Texas). The dilutions used for creating the standard curves included at least 4 data points spanning 4-5 orders of magnitude with a correlation coefficient (r) > 0.9 for all experiments and genes.
Sequencing of RT-PCR products
PCR-products of the I-Cycler runs were used for ligation into the pGEM-T vector (Promega). Colonies were grown overnight on microtiter plates and an aliquot was processed further as a template in a "sequencing" -PCR (30 s at 96ºC, 5 s at 50ºC, 60 s at 60ºC) using vector-specific primers from the manufacturer (Promega). Sequencing was done with the ABI 3700 Genetic Analyzer (PE Applied Biosystems) following the instructions of the manufacturer. The sequences were analyzed with the NCBI Program Blast Search (WWW.NCBI.NLM.NIH.GOV/Blast).
Culture of undifferentiated ES cells and differentiation into ES-HPC
ES cells of line R1 were cultivated on a feeder layer of primary mouse embryonic fibroblasts in the presence of recombinant human leukemia inhibitory factor (LIF) as described (Nagy et al., 1993; Wobus et al., 2002) .
For hepatic differentiation, ES cells (n = 600) were used to form embryoid bodies (EBs) that were cultivated in hanging drops as described elsewhere. At day 5, EBs were plated onto collagen type I-coated plates in Hepatocyte Culture Medium (Clonetics, Bio-Whittaker; A Cambrex Company; Belgium) supplemented with 20% FCS (Gibco BRL, Life Technologies, Eggenstein, Germany) and penicillin-streptomycin (Gibco, stock solution diluted 1:100) . The cells were cultivated until day 5+30. Samples for "real-time" RT-PCR and immunofluorescence analyzes were collected at stages 5+10d, 5+20d, 5+30d.
Immunofluorescence analysis
For immunofluorescence, ES-HPC at stage 5+20d were fixed with methanol: aceton (7:3) at -20ºC for 10 min. Bovine serum Albumin (1% in PBS) was used to inhibit unspecific labelling (30 min at room temperature). The following primary antibodies were used: goat anti-·-fetoprotein (1:100; Santa Cruz Biotechnol., USA), Albumin (1: 100; Serotec, USA). Cy 3TM -conjugated donkey anti-goat IgG and FITC-conjugated donkey anti-sheep IgG (both from Jackson ImmunoResearch Laboratories, PA) were used as secondary antibodies. To label the nuclei for a semi-quantitative estimation of immunofluorescence signals, cells were incubated in 5 µg/ ml Hoechst 33342 in PBS at 37ºC for 10 min. After washing in PBS (3x) and in aqua dest. (1x), the specimens were embedded in mounting medium (Vectashield, Vector Laboratories Inc., Burlingame, CA, USA).
Labelled cells were analyzed by the confocal laser scanning microscope (CLSM) LSM-410 (Carl Zeiss, Jena, Germany) using the following excitation lines/barrier filters: 364 nm/450-490BP (Hoechst 33342), 488 nm/510-525BP (FITC/DTAF), 543 nm/570LP (Cy3).
Determination of percentage values of Hoechst-labelled cells
Cells were analyzed for immunofluorescence signals and the percentage number of immunopositive cells relative to a total number of (n = 1000) Hoechst 33342-labelled cells is given.
Liver perfusion and hepatocyte cell culture
Hepatocytes were isolated from livers of BALB/C mice by a standard two-step collagenase perfusion (Seglen, 1979) . Viability (75% +/-6%) was estimated by trypan blue dye exclusion. Hepatocytes were plated at a density of 5x10 5 viable cells on collagen-coated cell culture dishes with a diameter of 35 mm in 2 ml culture medium supplemented with 10% FCS and incubated at 37°C in a humidified atmosphere composed of 95% air and 5% CO 2 . RNA was prepared from hepatocytes after 24 h and 48 h in culture and analyzed for expression of ALB, AFP, HNF-3β, HNF-4α and HNF-6 by quantitative RT-PCR.
Statistical analysis
Data are presented as means ± SD. Statistical analysis was performed with the Sigma Stat Software (Sigma, St. Louis, U.S.A). The paired Student´s t -test was used for all data. A p value < 0.05 was considered to be significant.
